Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 122 of 122 entries
View as:

Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance

Phase: N/A Priority: Normal
NCT ID: NCT06043973 Org: User:
Start: 09/01/23 End: 06/30/27 Due: 06/30/28

Risk Factors and Machine Learning Model for Proton Pump Inhibitor Related Acute Kidney Injury

Phase: N/A Priority: Normal
NCT ID: NCT05533619 Org: User:
Start: 07/01/22 End: 10/31/23 Due: 10/31/24

Study on the Efficacy and Safety of Conversion Therapy in Patients With Initially Unresectable Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06365034 Org: User:
Start: 03/01/24 End: 01/31/25 Due: 01/31/26

Sedation of Remazolam Combined With Afentanil in Non-intubated Thoracoscopic Pulmonary Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06810843 Org: User:
Start: 04/30/25 End: 12/31/27 Due: 12/31/28

Efficacy and Safety of Long-term Oral Staphylococcus Albicans Tablets in Patients With Bronchiectasis

Phase: N/A Priority: Normal
NCT ID: NCT05407792 Org: User:
Start: 06/06/22 End: 12/31/26 Due: 12/31/27

Effect of Daytime Variation on PPCs in Lung Resection Surgery.

Phase: N/A Priority: Normal
NCT ID: NCT05582291 Org: User:
Start: 01/12/22 End: 09/20/22 Due: 09/20/23

Characteristics of Hospitalized Patients With Community-acquired Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT06065618 Org: User:
Start: 09/22/23 End: 09/22/24 Due: 09/22/25

MNCs for Bone Marrow Failure After Malignant Diseases Children Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05628272 Org: User:
Start: 10/01/22 End: 09/01/24 Due: 09/01/25

Evaluation for Benign and Malignant Pulmonary Ground-glass Nodules Based on MRI Dynamic Contrast Enhanced Imaging

Phase: N/A Priority: Normal
NCT ID: NCT05067023 Org: User:
Start: 11/20/21 End: 03/15/23 Due: 03/15/24

NPC1L1 Gene Polymorphism and the Efficacy and Safety of Hybutimibe

Phase: N/A Priority: Normal
NCT ID: NCT06641661 Org: User:
Start: 11/01/24 End: 06/30/27 Due: 06/30/28

Treatment of HPV Infection in Perimenopausal and Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT05863975 Org: User:
Start: 07/01/23 End: 12/31/25 Due: 12/31/26

The Effect of Pituitrin on the Patients With Pulmonary Hypertension Undergoing Cardiac Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05727618 Org: User:
Start: 05/01/26 End: 02/01/29 Due: 02/01/30

Efficacy and Safety Study of Medical Thoracoscope Cryotherapy Combined Standard First-line Treatment of Advanced Non-small Cell Lung Cancer and Malignant Pleural Effusion

Phase: N/A Priority: Normal
NCT ID: NCT05291403 Org: User:
Start: 04/06/22 End: 12/31/24 Due: 12/31/25

Study on the Application of Hyperspectral Imaging Technique in the Treatment of IMN by TAC

Phase: N/A Priority: Normal
NCT ID: NCT05797038 Org: User:
Start: 04/25/23 End: 12/30/23 Due: 12/30/24

Risk Analysis of Cardiotoxic Medication Use Due to Sodium Arsenite Chloride Injection

Phase: N/A Priority: Normal
NCT ID: NCT06060132 Org: User:
Start: 01/29/23 End: 12/31/23 Due: 12/31/24

Combination Therapy of Omalizumab and Allergen Immunotherapy for Moderate to Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT06771934 Org: User:
Start: 06/01/24 End: 06/30/25 Due: 06/30/26

Correlation Between Modified Weakness Index and Postoperative Delirium in Elderly Patients

Phase: N/A Priority: Normal
NCT ID: NCT05189678 Org: User:
Start: 11/22/21 End: 08/31/22 Due: 08/31/23

Quantitative US for Evaluation of Hepatic Steatosis in MAFLD With UDFF

Phase: N/A Priority: Normal
NCT ID: NCT06097338 Org: User:
Start: 10/31/23 End: 09/30/26 Due: 09/30/27

Clinical Study on the Effect of Selenium Yeast Capsule on Prognosis of Differentiated Thyroid Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04683575 Org: User:
Start: 05/30/22 End: 12/31/25 Due: 12/31/26

Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world, Multicenter Study

Phase: N/A Priority: Normal
NCT ID: NCT06753981 Org: User:
Start: 12/10/24 End: 02/14/27 Due: 02/14/28

Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients

Phase: N/A Priority: Normal
NCT ID: NCT06883136 Org: User:
Start: 03/12/25 End: 06/29/27 Due: 06/29/28

Risk Factors and Machine Learning Model for Aminoglycines Related Acute Kidney Injury

Phase: N/A Priority: Normal
NCT ID: NCT05533593 Org: User:
Start: 07/01/22 End: 10/31/23 Due: 10/31/24